If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksESKN.L Regulatory News (ESKN)

  • There is currently no data for ESKN

Response to press speculation

31 Oct 2023 07:00

RNS Number : 7842R
Esken Limited
31 October 2023
 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

31 October 2023

 

ESKEN LIMITED

('Esken' or 'the Group')

 

Response to press speculation

 

Esken Limited, the aviation and energy infrastructure groupnotes the recent press speculation regarding Esken Renewables.

The Group confirms that in accordance with the previously announced strategic review of its operating businesses, it is in advanced discussions with Pioneer Point Partners regarding a possible disposal of the entire issued share capital of Esken Renewables.

Should the Group complete the disposal of Esken Renewables, the net proceeds would be used to: repay the committed funding drawn under the Group's facilities agreement with the specialty lender and associated costs; further contribute to the Group's defined benefit pension scheme; and provide additional working capital in the short term.

Discussions are ongoing and there can be no certainty that any transaction will be agreed or, if so, on what terms.

 

A further announcement will be made shortly.

 

This announcement contains inside information. The person responsible for arranging this announcement on behalf of Esken is Adam Davidson, General Counsel and Company Secretary. 

 

Enquiries:

 

Esken Limited C/o Teneo

 

Teneo

Olivia Peters / Giles Kernick T: +44 (0)20 7353 4200 

E: esken@teneo.com

 

TB Cardew, PR Advisers to Pioneer Point Partners

Tom Allison T: +44 (0) 7789 998 020

Henry Crane T: +44 (0) 7918 207157

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCNKKBQBBDBOKN
Date   Source Headline
21st Dec 20224:35 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20224:35 pmRNSPrice Monitoring Extension
8th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:36 pmRNSPrice Monitoring Extension
29th Nov 20221:49 pmRNSResult of EGM
24th Nov 20224:35 pmRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSTR-1
9th Nov 20227:00 amRNSInterim Results
9th Nov 20227:00 amRNSNotice of EGM
3rd Nov 20227:00 amRNSNotice of Results
19th Oct 202210:18 amRNSTR-1
12th Sep 20224:41 pmRNSSecond Price Monitoring Extn
12th Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 202210:53 amRNSListing Rule 9.6.14(2) Disclosure
31st Aug 20227:00 amRNSTrading Statement
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
10th Aug 20224:35 pmRNSPrice Monitoring Extension
5th Aug 202210:59 amRNSTR-1
28th Jul 20224:35 pmRNSPrice Monitoring Extension
13th Jul 20222:43 pmRNSAGM results
5th Jul 20224:35 pmRNSPrice Monitoring Extension
5th Jul 20227:00 amRNSDirector/PDMR Shareholding
30th Jun 20227:00 amRNSAudit tender outcome and annual general meeting
23rd Jun 20224:35 pmRNSPrice Monitoring Extension
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:37 pmRNSPrice Monitoring Extension
16th Jun 20222:27 pmRNSDirector/PDMR Shareholding
13th Jun 20224:36 pmRNSPrice Monitoring Extension
13th Jun 20223:28 pmRNSPosting of Annual Report and Notice of AGM
10th Jun 20224:36 pmRNSPrice Monitoring Extension
8th Jun 20224:35 pmRNSPrice Monitoring Extension
1st Jun 20224:36 pmRNSPrice Monitoring Extension
27th May 20224:40 pmRNSSecond Price Monitoring Extn
27th May 20224:35 pmRNSPrice Monitoring Extension
25th May 20227:00 amRNSFinal Results
18th May 20221:03 pmRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSNotice of Results
12th May 20224:42 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
30th Mar 20224:35 pmRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSTrading Statement
11th Mar 20224:35 pmRNSPrice Monitoring Extension
4th Mar 20224:42 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20227:00 amRNSAppointment of Joint Broker
18th Feb 20224:40 pmRNSSecond Price Monitoring Extn
18th Feb 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.